CompletedNCT04452604
Multicentric Registry of Patients With Acute Leukemia Infected by COVID-19
Studying Acute lymphoblastic leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- French Innovative Leukemia Organisation
- Principal Investigator
- Pierre-Yves DUMAS, DrFrench Innovative Leukemia Organisation
- Enrollment
- 79 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2020 – 2021
Study locations (27)
- Chu Amiens, Amiens, France
- CHU ANGERS - Maladies du sang, Angers, France
- Ch Avignon, Avignon, France
- CH de la Côte Basque - Hématologie, Bayonne, France
- CHU Caen - IHBN - Hématologie Clinique, Caen, France
- Centre Hospitalier Sud Francilien, Corbeil-Essonnes, France
- Centre Hospitalier de Dunkerque, Dunkirk, France
- CHU de Grenoble - Hopital Michallon, Grenoble, France
- Centre Hospitalier du Mans, Le Mans, France
- Hôpital Saint Vicent de Paul, Lille, France
- Chu Limoges, Limoges, France
- Institut Paoli-Calmettes - Hématologie 2, Marseille, France
- HOPITAL SAINT ELOI - Hematologie, Montpellier, France
- HOPITAL E. MULLER - Hématologie, Mulhouse, France
- CHU HOTEL DIEU - Hématologie Clinique, Nantes, France
- +12 more locations on ClinicalTrials.gov
Collaborators
Acute Leukemia French Association · Group for Research in Adult Acute Lymphoblastic Leukemia
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04452604 on ClinicalTrials.govOther trials for Acute lymphoblastic leukemia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT05621291A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu...National Cancer Institute (NCI)
- RECRUITINGPHASE2NCT07328503CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic LeukemiaNational Cancer Institute (NCI)
- ENROLLING BY INVITATIONNCT07511959Autologous Exosomes From Platelet-rich Plasma as a Modern Tool of Regenerative DentistryWroclaw Medical University
- RECRUITINGPHASE2NCT06738368Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic LeukemiaUniversity of Washington
- RECRUITINGNANCT07191119Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic LeukemiaSt. Jude Children's Research Hospital
- RECRUITINGPHASE2NCT07275762Y-4 to Treat the Postherpetic NeuralgiaNeurodawn Pharmaceutical Co., Ltd.
- RECRUITINGNANCT07177183Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning FailureUniversity Hospital Ostrava
- RECRUITINGNANCT07201974Virtual Reality for Post-Stroke Gait RehabilitationMcGill University